INTRODUCTION
L-erythro-5,6,7,8-Tetrahydrobiopterin (tetrahydrobiopterin) is an essential cofactor of phenylalanine-4-, tyrosine-3-and tryptophan-5-mono-oxygenase [1] , but is also synthesized in tissues lacking either of these three mono-oxygenases, suggesting further, still unknown, metabolic functions of tetrahydrobiopterin [2] . The key step of tetrahydrobiopterin biosynthesis is the cleavage of GTP to 7,8-dihydroneopterin triphosphate by the enzyme GTP cyclohydrolase I (EC 3.5.4.16) [3] .
D-erythro-6-(1',2',3'-Trihydroxypropyl)pterin (neopterin) accumulates in body fluids of patients suffering from an inborn deficiency in tetrahydrobiopterin biosynthesis downstream from the first intermediate, 7,8-dihydroneopterin triphosphate [4] . Besides this extremely rare inherited disorder, neopterin was shown to be elevated in the panel of diseases challenging cell-mediated immunity [5] [6] [7] . In contrast with deficiency of tetrahydrobiopterin synthesis, where biopterin levels are substantially lower than in healthy controls, the highly elevated neopterin levels in infectious diseases are paralleled by slightly elevated biopterin levels [8] . In vitro, large amounts of neopterin were found to be released from macrophages upon stimulation by interferon-y (IFN-y) derived from activated T-lymphocytes [9] .
In macrophage cultures [10] as well as in body fluids of patients [1 1], IFN-y-induced pteridine synthesis is closely correlated with degradation of the essential amino acid tryptophan. This degradation is initiated by indoleamine 2,3-dioxygenase (IDO) (EC 1.13.11.17), which cleaves tryptophan to N-formylkynurenine [12] . IDO is strongly induced by IFN-y in various human cells and is thought to play a role in host defence mechanisms against parasites and tumours [13] [14] [15] .
Tetrahydrobiopterin has been shown to act as cofactor in IDO preparations purified from rabbit intestine [16] and mouse epididymis [17] , but the physiological significance of this finding remained elusive. If tetrahydrobiopterin was functionally connected with IDO in human cells also, pteridine synthesis should be induced together with this enzyme not only in macrophages, but also in any other cell with inducible IDO activity.
We therefore investigated pteridine synthesis in six human tumour-cell lines of various tissue origin, in human dermal fibroblasts and in human peripheralblood monocyte-derived macrophages, which all degrade tryptophan when treated with IFN-y.
MATERIALS AND METHODS

Materials
Pteridine derivatives were from Schircks (Jona, Switzerland). Sephadex G-25, Ficoll-Paque and Percoll were from Pharmacia (Uppsala, Sweden). L-Tryptophan was from Calbiochem (Los Angeles, CA, U.S.A.). D-Tryptophan, L-kynurenine, 4',6-diamidino-2-phenylindole (DAPI), trypsin/EDTA solution, pyruvic acid and antibiotics were purchased from Sigma (Munich, Germany). Bovine liver catalase (EC 1.11.1.6), calf intestine alkaline phosphatase (EC 3.1.3.1), GTP disodium salt, Dulbecco's modified Eagle's medium (DMEM), Eagle's minimum essential medium (MEM) with Earle'ssalts base and pure bovine serum albumin were from Serva (Heidelberg, Germany). RPMI 1640 (low endotoxin) and foetal-calf serum (FCS) were products from Biochrom (Berlin, Germany). RPMI 1640 Select Amine Kit was from Gibco (Grand Island, NY, U.S.A.). Recombinant human IFN-y with an activity of 2 x 107 i.u./mg of protein was a gift from Bioferon (Laupheim, Germany). Cell-culture plasticware was from Falcon (Becton-Dickinson, Lincoln Park, NJ,
Cell culture
Human cell lines A 431 (epidermoid carcinoma) [18] , A 498 (kidney carcinoma) [18] , A 549 (lung carcinoma) [19] , SK-HEP-1 (liver carcinoma) [20] , U 138 MG (glioblastoma) [21] , T 24 (bladder transitional-cell carcinoma) [22] and normal dermal fibroblasts were either obtained directly from the American Type Culture Collection (Rockville, MD, U.S.A.) or kindly supplied by various institutions of the University of Innsbruck. Buffy coats from blood of healthy donors and human serum were generously provided by the Blood Transfusion Center of the University Hospital of Innsbruck.
T 24 was grown in MEM with Earle's-salts base supplemented with 10 00(v/v) heat-inactivated FCS, 2 mM-L-glutamine, 100 i.u. of penicillin/ml and 0.1 ng of streptomycin/ml. The same medium with a further addition of 1 mM-pyruvic acid was used for A 498 and U 138 MG. A 431, A 549 and fibroblasts of passages [16] [17] [18] [19] [20] [21] [22] [23] were cultivated in DMEM with supplements as described for T 24. For SK-HEP-1, DMEM with the same supplements but a further addition of 1 mM-pyruvic acid, was used. The pyruvic acid added is required for optimal growth of the respective cell lines. All cell lines were mycoplasma-negative as tested by staining with DAPI [23] and have been reported to be free of HeLa-cell markers [24] . Depending on the cell line used, the seeding density was (1) (2) (3) (4) (5) x 104 cells/cm2.
Peripheral-blood-derived monocytes were enriched from buffy coats gf healthy blood donors by a two-step density-gradient centrifugation over Ficoll-Paque [25] and a discontinuous Percoll gradient [26] . Cells were seeded in 10 ml of RPMI 1640 (low endotoxin) with 10 % heat-inactivated human pooled serum, 2 mM-Lglutamine and antibiotics (see above) at a density of 106/ml in plastic Petri dishes and allowed to adhere. Washing of plates with warm phosphate-buffered saline (PBS) after 2 and a further 24 policeman. Suspensions of interferon-treated and control plates were pooled separately. Cell viability after applying either of these procedures was less than 50 as determined by staining with Trypan Blue.
Extracts were applied to Sephadex G-25 columns (3 cm x 0.5 cm) after centrifugation for 10 min at 10000 g. The protein fraction was eluted with 0.1 MTris/HCl (pH 7.8)/5 mM-EDTA/0.3 M-KCl/10 Qo (v/v) glycerol.
Only freshly harvested cell extracts were used, as GTP cyclohydrolase I activity and the tetrahydrobiopterin content decreased in some cases to less than 300 already after overnight storage at -20 'C.
Protein determination
Protein contents of cell extracts and eluates were determined as described by Bradford [27] using freezedried pure bovine serum albumin as standard.
Enzyme assays GTP cyclohydrolase I assay was carried out as described by Viveros et al. [28] using 100-900,g of cell protein.
Briefly, the eluate was incubated with 2 mM-GTP for 90 min at 37 'C. The 7,8-dihydroneopterin triphosphate thus formed was then first oxidized to neopterin triphosphate by addition of acidic iodine solution and then dephosphorylated to neopterin by alkaline phosphatase. Neopterin in incubation mixtures was quantified by solid-phase-extraction on-line-elution h.p.l.c. [29] . Under these conditions, reaction rates increased linearly up to 4.5 mg of protein [30] .
Assay for IDO activity was performed in eluates of cell extracts using a method based on the quantification of kynurenine by h.p.l.c. as previously described [31] . The reaction mixture contained 0.1 M-potassium phosphate buffer, pH 7. 
Pteridine determinations
Total neopterin and biopterin in cell extracts and supernatants were quantified after acid-iodine oxidation by solid-phase-extraction on-line-elution h.p.l.c. [29] .
Briefly, 100 #1 of cell extracts (500,tl in the case of macrophages) or supernatants were mixed with 5 ,ul of 10 M-H3PO4 and 5 pul of 0.1 M-KI/12 and incubated for 1 h in the dark. For determination of the amount of biopterin and 7,8-dihydrobiopterin, H3P04 was replaced by 5 ,1 of 1 M-NaOH. For the measurement of neopterin without inclusion of reduced derivatives, 100 u1 of the sample was incubated with 10 ,ul of 0.1 M-Fe3+-EDTA. After incubation, the reaction mixture was acidified by addition of 5 ,u of 10 M-H3PO4 and 5 ,ul of 1 M-ascorbic acid, which also served to destroy remaining iodine. The incubation mixtures were then extracted with AASP-SCX cartridges (Analytichem, Harbor City, CA, U.S.A.) and the pteridines directly eluted on to a reversed-phase h.p.l.c. column and quantified by fluorescence detection as described in [29] . Determination of kynurenine in culture supernatants Kynurenine in supernatants was quantified by reversed-phase h.p.l.c. with u.v. detection as described in ' [10] .
1989 Table 1 . Activities of IDO, GTP cyclohydrolase I and pteridine concentrations in extracts of human cells after IFN-y treatment as compared with untreated controls Cells were cultivated for 48 h with 250 i.u. of IFN-y/ml or without IFN-y, and cell extracts were obtained as detailed in the Materials and methods section. Activity of IDO was assessed by h.p.l.c. measurement of the kynurenine formed from tryptophan in 10 min at 37 'C. Activity of GTP cyclohydrolase I (GTP-CH) was determined by quantification of the amount of neopterin derivatives formed from GTP in 90 min at 37 'C. Neopterin derivatives were measured as neopterin by h.p.l.c. after oxidation with acidic iodine and dephosphorylation with alkaline phosphatase. Intracellular neopterin and biopterin concentrations were determined by h.p.l.c. after oxidation by acidic iodine. Data expressed in the Derivatization of biopterin to pterin-6-carboxylic acid Extract of T 24 cells treated with 250 i.u. of IFN-y/ml (containing 2.5 mg of cell protein) (600 ml) was oxidized in acidic-iodine solution, extracted and eluted to the h.p.l.c. system as described above. The intense fluorescent peak at the retention time of biopterin was collected. Of this fraction, 100 4tl was then incubated with 10 
RESULTS
Concerted induction of tetrahydrobiopterin biosynthesis
and IDO by IFN-y Table 1 shows IDO activity and pteridine synthesis of six human tumour-cell lines from various tissue origins, of human dermal fibroblasts and of human macrophages derived from peripheral-blood monocytes. Activity of GTP cyclohydrolase, the key enzyme of pteridine biosynthesis and intracellular concentrations of neopterin and biopterin were distinctly increased by IFN-y in all cells investigated. T 24 cells, the only cells with constitutive IDO activity, showed considerable pteridine synthesis also when unstimulated. Chemical identity of biopterin was confirmed with a fraction purified by h.p.l.c. from cell extract of IFN-y-stimulated T 24 cells, which showed fluorescence spectra identical with that of Vol. 262 for three experiments. amounts of neopterin are less than, or equal to, that of biopterin (Table 1) . Further, only in IFN-y-treated macrophages was monapterin [L-threo-6-(l',2',3'-trihydroxypropyl)pterin] detected (11.12 + 3.26 pmol mg of protein-1; mean + S.D. of five observations). The magnitude of GTP-cyclohydrolase I, of intracellular neopterin and of intracellular biopterin concentrations was not significantly (P > 0.10) correlated with the magnitude of the IDO activity. The values for GTP cyclohydrolase correlated significantly only with the sum of neopterin plus biopterin (P = 0.00019), but not with neopterin (P = 0.11) or biopterin (P = 0.06) concentrations alone (linear correlation analysis; calculated from Table 1 ). Release of pteridines into the supernatant by IFN-y-treated human ceUs
To estimate the potential contribution of the various cells to the pteridine patterns observed in body fluids of patients, we examined the amounts of neopterin and biopterin released by IFN-y-stimulated cells into the supernatant (Table 2 ). Macrophages are the most potent producers of neopterin. Although T 24 cells have an even higher GTP cyclohydrolase I activity and intracellular pteridine concentration than macrophages (Table 1) , only a much smaller amount of biopterin leaks to the supernatant (Table 2) . Comparing intracellular and extracellular concentrations of pteridines in A 431, A 498 and U 138 MG cells ( Table 1 ) also indicates that biopterin derivatives synthesized are retained within the cells more efficiently than are neopterin derivatives. Cofactor activity of tetrahydrobiopterin in the IDO reaction Cofactor activity of tetrahydrobiopterin towards IDO was tested in human cell extracts, activity which had thus far only been described for rabbit [16] or mouse [17] tissue. For this purpose, eluates of IFN-y-treated T 24 cells were incubated with Methylene Blue, catalase and various concentrations of either tetrahydrobiopterin or ascorbic acid (Fig. 1) . Whereas tetrahydrobiopterin at 70,mol/I stimulated the IDO reaction to half-maximal activity, ascorbic acid at 1300 #tmol/I was required for half-maximal stimulation. At saturating conditions, tetrahydrobiopterin gave only one quarter of the turnover achieved by ascorbic acid (Fig. 1) Fig. 2 . Increase in the L-tryptophan content of the culture medium was paralleled by both increased IDO activity and pteridine synthesis (P < 0.0001 and P < 0.0002; linear regression analysis). As a control, corresponding amounts of D-tryptophan did not show a comparable effect (Fig. 2) . Addition of L-kynurenine, which is readily In contrast with macrophages, increase of extracellular L-tryptophan leads to a decrease of IDO activity in T 24 cells [31] . In T 24 cells stimulated with IFN-y (10 units/ml) for 24 h, GTP cyclohydrolase activities (in pmol/min per mg) were 1.1 1 and 1.13 at an extracellular L-tryptophan concentration of 50
StM and decreased to 0.577 and 0.556 at 500 /LM extracellular L-tryptophan.
DISCUSSION
The results presented here demonstrate that IFN-yinduced pteridine synthesis is a more general phenomenon than production of neopterin derivatives by macrophages [9, 34] . It is observed in a variety of human cells of various tissue origin and yields tetrahydrobiopterin, the active form of a hydroxylating cofactor. Compared with other inducers of GTP cyclohydrolase I, like reserpine or insulin, which in rat adrenal medulla were shown to lead to 2-fold increases of activity [28] , IFN-y is a far better inducer, causing 5-100-fold increases in GTP cyclohydrolase I activity. In contrast with previous observations [34] , we were able to detect small amounts of biopterin derivatives in macrophages. This may be due to the more sensitive methods used here. The ratio of neopterin to biopterin in the cells varies from 0.02 in T 24 tm 0.80 in U 138 and 72.9 in macrophages (calculated from Table 1 ). This may be caused by different relative activities of GTP cyclohydrolase I compared with the enzymes converting dihydroneopterin triphosphate to tetrahydrobiopterin. Depending on the cell type, this ratio might also be influenced by factors determining the chemical stability of dihydroneopterin triphosphate or tetrahydrobiopterin.
Dihydroneopterin and tetrahydrobiopterin were shown to be equally potent feedback inhibitors of GTP cyclohydrolase I [35] . This is consistent with our finding that GTP cyclohydrolase I activities correlated with the sum of neopterin plus biopterin rather than with neopterin or biopterin alone. In body fluids of patients treated with IFN-y, pronounced increases in neopterin derivatives were accompanied only by much smaller rises in biopterin concentrations [11] . This is compatible with our observation that the neopterin derivatives formed upon IFN-y treatment are more readily released than tetrahydrobiopterin. Increase in tryptophan in the culture medium led to decreased IDO and GTP cyclohydrolase activities in the tumour cell line T 24. Whether this is functionally related to the reported ability of tryptophan to inhibit the antiproliferative effect ofIFN-y [36] remains to be demonstrated. In contrast, macrophages appear to be peculiar in that both enzyme activities increase upon increase of extracellular tryptophan.
The physiological significance of IFN-y-induced tetrahydrobiopterin biosynthesis remains to be established. It has never been reported, nor show here that alterations ofIDO activity by the substrate L-tryptophan are paralleled by changes in the activity of GTP cyclohydroxylase I, the key enzyme of tetrahydrobiopterin biosynthesis. We have therefore considered the possibility of an involvement of tetrahydrobiopterin in the IDO reaction. Tetrahydrobiopterin could contribute to this reaction by activation of one of the two oxygen atoms introduced into the tryptophan molecule by IDO, similar to the mechanism in pterin-dependent amino acid hydroxylases [1] . In addition, tetrahydrobiopterin might act by maintaining the catalytically active iron in the ferrous state.
The nature of the physiological cofactor of IDO has not yet been identified unambiguously. In vitro, IDO is known to require Methylene Blue and ascorbic acid for full activity. With enzyme purified from mouse epididymis, FMNH2 has been found to lead to the highest turnover rates [37] . We could not confirm this stimulatory action of FMNH2 in human T 24 cell extracts [31] . On the basis of investigations with IDO purified from rabbit intestine [16] or mouse epididymis [17] , tetrahydrobiopterin has been suggested to be a physiological cofactor of the IDO reaction. We demonstrate here that, in extracts of human T 24 cells also, the IDO reaction is stimulated by submillimolar concentrations of tetrahydrobiopterin. However, the additional requirement of Methylene Blue indicates that the tetrahydrobiopterindependent contribution to the IDO reaction may be only a part of a complex mechanism.
Although our results provide several lines of evidence for a functional significance of tetrahydrobiopterin in the IDO reaction, it cannot be ruled out at present that tetrahydrobiopterin is involved in a reaction other than those discussed here, e.g. in the cleavage of ether lipids [38] .
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